EGFR and cancer: The low-m6AlncRNAscore group was characterized by enrichment of immunosuppressive, stromal, and carcinogenic activation pathways such as wnt signaling pathway, TGF beta signaling pathway, MAPK signaling pathway, ERBB signaling pathway, focal adhesion, extracellular matrix (ECM)-receptor interaction, and pathways in cancer (Fig. 5a).